in this issue
Regions :: Western Europe
Bayer raises offer for Norwegian pharmaceutical firm Algeta to $2.9 billion
7:50 AM MST | December 19, 2013 | Deepti Ramesh
Bayer says it will launch a voluntary cash offer to acquire the entire issued share capital of Norwegian pharmaceutical company Algeta (Oslo) for 362 Norwegian kroner ($59) per Algeta share. The offer values the total share capital of Algeta at about $2.9 billion. Bayer had offered, last month, to pay 336 Norwegian kroner per Algeta share, valuing the bid at $2.4 billion. The board of directors of Algeta has unanimously decided to recommend that its shareholders accept the new offer. The offer price represents a premium of 37% over the closing price on 25...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee